Adamis Pharmaceuticals reported $-8113330 in Operating Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Adma Biologics ADMA:US USD 22.12M 31.29M
Brainstorm Cell Therapeutics BCLI:US USD -6841000 750K
Cara Therapeutics CARA:US USD -23845000 19.37M
GlaxoSmithKline GSK:LN GBP 1.87B 677M
Glaxosmithkline GSK:US GBP 1.87B 677M
Merk MRK:US USD 3.51B 505M
Pfizer PFE:US USD 5.17B 4.24B